Preeclampsia Clinical Trial
Official title:
The Effect of Mindfulness Breath Awareness Meditation on Health Profile, Vital Signs, and Fetal Heart Rate in Pregnant Women Diagnosed With Preeclampsia
Verified date | March 2024 |
Source | University of Gaziantep |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The effect of mindfulness breath awareness meditation on health profile, vital signs, and fetal heart rate in pregnant women with preeclampsia
Status | Recruiting |
Enrollment | 66 |
Est. completion date | April 1, 2024 |
Est. primary completion date | April 1, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 19 Years to 49 Years |
Eligibility | Inclusion Criteria: - pregnant women who is admitted to the Perinatology Service of the hospital with the diagnosis of preeclampsia, - who is 19 to 49 years old, - who is 20 and over weeks of gestation, - who followes by at least three days of hospitalization in the ward. Exclusion Criteria: - Pregnant women who do not meet the inclusion criteria and who voluntarily withdraw at any stage after inclusion will be excluded from the study. |
Country | Name | City | State |
---|---|---|---|
Turkey | Sanliurfa training and research hospital | Sanliurfa | Eyalet/Yerleske |
Lead Sponsor | Collaborator |
---|---|
Aysegul Kilicli |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Nottingham Health Profile | Nottingham Health Profile The scale consists of 38 questions and 6 sub-dimensions. The scale consists of 8 questions on physical activity (PA), 8 questions on pain (P), 5 questions on sleep (S), 3 questions on energy level (EL), 9 questions on emotional reactions (ER), 5 questions on social isolation (SI). Questions are answered as 'yes' or 'no', item score calculations in each sub-dimension differ, the best score that can be obtained from each sub-dimension is '0' and the worst score is '100'. The minimum score that can be obtained from the whole scale is 0 and the maximum score is 600. Quality of life improves as the score decreases. | It will be evaluated before the first application and then every 24 hours for a total of 4 times | |
Primary | Fetal heart rate | Fetal heart rate | It will be evaluated before the first application and then every 24 hours for a total of 4 times | |
Primary | Body temperature | Body temperature | It will be evaluated before the first application and then every 24 hours for a total of 4 times | |
Primary | Pulse | Pulse | It will be evaluated before the first application and then every 24 hours for a total of 4 times | |
Primary | Systolic blood pressure | Systolic blood pressure | It will be evaluated before the first application and then every 24 hours for a total of 4 times | |
Primary | Diastolic blood pressure | Diastolic blood pressure | It will be evaluated before the first application and then every 24 hours for a total of 4 times | |
Primary | Respiratory rate | Respiratory rate | It will be evaluated before the first application and then every 24 hours for a total of 4 times | |
Primary | Oxygen saturation | Oxygen saturation | It will be evaluated before the first application and then every 24 hours for a total of 4 times | |
Secondary | fetal movement count | fetal movement count | It will be evaluated before the first application and then every 24 hours for a total of 4 times | |
Secondary | Nottingham Health Profile subdimensions | Nottingham Health Profile subdimensions physical activity, pain, sleep, energy, emotional reactions, and social isolation | It will be evaluated before the first application and then every 24 hours for a total of 4 times |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03510286 -
Validation of a PrCr Dipstick Diagnostic Test in Ghana
|
||
Recruiting |
NCT03313024 -
Berlin-Brandenburg Pregnancy Cohort
|
||
Active, not recruiting |
NCT04990141 -
Molecular Screening Method for Preeclampsia (PREMOM)
|
||
Completed |
NCT02147626 -
Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia
|
N/A | |
Not yet recruiting |
NCT05999851 -
Multiparametric Assessment of Maternal Vascular Function in the Prediction of Hypertensive Disorders of Pregnancy
|
N/A | |
Recruiting |
NCT02923206 -
Proof-of-Concept Trial on Selective Removal of sFlt-1 in Pregnant Women With Preeclampsia Via Apheresis
|
N/A | |
Terminated |
NCT02558023 -
The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus Nicardipine
|
Phase 3 | |
Completed |
NCT02554604 -
Identifying HDL Composition and Function in Preeclamptic and Normal Pregnancies
|
||
Completed |
NCT02854501 -
Second Trimester Maternal Serum Homocysteine Levels and Uterine Artery Doppler for Prediction of Preeclampsia and Placentation Disorders
|
||
Withdrawn |
NCT05016440 -
Lisinopril for Renal Protection in Postpartum Preeclamptic Women
|
N/A | |
Not yet recruiting |
NCT02541110 -
Prediction of Preeclampsia & Other Obstetric Complications by Serum Homocysteine & Doppler
|
N/A | |
Completed |
NCT02384226 -
User Testing and Feedback for a Mobile Health Program for Postpartum Women: A Pilot Study
|
||
Recruiting |
NCT02247297 -
Pancreatic Stone Protein (PSP) in Pregnant Women
|
||
Recruiting |
NCT02337049 -
Preeclampsia Subtypes and Surrogate Markers of CVD Risk
|
N/A | |
Completed |
NCT02238704 -
Cornell University-Micronutrient Initiative Calcium Supplementation Study
|
N/A | |
Completed |
NCT01195441 -
Prediction and Prevention of Preeclampsia by First Trimester Ultrasound
|
N/A | |
Withdrawn |
NCT01179542 -
The Involvement of Eukaryotic Translation Initiation Factor 4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR
|
N/A | |
Completed |
NCT00456118 -
Study of the Role of Tissular Maternofetal Alloimmunization in Placentation Pathologies
|
||
Recruiting |
NCT00117546 -
Cardiovascular and Autonomic Reactivity in Women With a History of Pre-eclampsia
|
Phase 4 | |
Completed |
NCT00787241 -
Platelet Count Trends in Pre-eclamptic Parturients
|
N/A |